Also found in: Acronyms.


The Consortium to Establish a Registry for Alzheimer's Disease. A neurological testing instrument used to assess patients with Alzheimer’s disease.

Verbal fluency test; Boston Naming Test; MMSE; 10-item word recall; constructional praxis; delayed recall of praxis items.

Time required
20–30 minutes.

Convenient and effective at assessing and tracking cognitive decline.
References in periodicals archive ?
EXAMPLE 5, SAMPLE AUTOPSY SICNOUT: * Alzheimer disease neuropathologic changes, "high", A3B3C2: *** Thal phase for amyloid plaques: 5 (A3) *** Braak and Braak neurofibrillary stage: VI (B3) *** CERAD neuritic plaque score: Moderate (C2) *** Cerebral amyloid angiopathy, diffuse *** TDP-43 proteinopathy, with: ** Hippocampal sclerosis, bilateral, severe ** Frequent pathologic inclusions in hippocampus proper, dentate gyrus, limbic regions, and basal forebrain * No Lewy body pathology is identified Comment: "High" AD neuropathologic change is identified, which per the 2012 NIA/AA guidelines is considered adequate explanation for clinical diagnosis of dementia in the appropriate context (Moline et al.
Which of the following statements is true of the CERAD criteria?
En comparacion con EA, los DTF tienen bajo rendimiento en la fluidez animal pero no en ninguna otra prueba del CERAD.
The CERAD Word List Memory task involves 10 printed words (Morris et al.
Recruitment of black elderly for clinical research studies of dementia: The CERAD experience.
A geriatrician or specially trained clinical research nurse performed the dementia evaluation using the CERAD clinical battery, which was designed to assess Alzheimer's disease and expanded to include non-Alzheimer's disease dementias [23].
grau de instrucao apresentaram melhor desempenho no subteste de nomeacao de Boston Cera, et al; (2011) CERAD Nao houve manifestacoes na fase inicial e moderada.
If their age-adjusted CERAD score was 35 or less, they were referred to a physician for a medical work-up.
2010) assessed the influence of age on cognitive performance in late adulthood with the CERAD battery.
The main outcome of interest was clinical impairment, which was defined as impaired cognition indicated by failing scores on the CERAD or the TICS-M.
Ribeiro, Oliveira, Cupertino, Neri e Yassuda (2010) avaliaram o desempenho de idosos na Bateria Cognitiva CERAD, comparando a variaveis socio-demograficas e saude percebida e tambem encontraram correlacao significante entre saude percebida e todas as habilidades avaliadas (exceto reconhecimento) com escolaridade, o que tambem reforca os achados do presente estudo.
In addition, residence within 50 m of a major road was adversely associated with performance on all subtests of the CERAD battery, although few individual associations achieved statistical significance.